Inhibition of proteoglycan synthesis affects neuronal outgrowth and astrocytic migration in organotypic cultures of fetal ventral mesencephalon

Journal of Neuroscience Research

Volumn 86, Issue 1, 2008, Pages 84-92

  Berglöf, Elisabet ^a   Plantman, Stefan ^b   Johansson, Saga ^c   Strömberg, Ingrid ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Astrocytes; Dopamine; Extracellular matrix; Neurocan; Substantia nigra

Indexed keywords

DOPAMINE; PROTEOGLYCAN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FETAL STEM CELL; GLIA CELL; MESENCEPHALON; NERVE CELL GROWTH; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ANIMALS; ANTIBODIES; ASTROCYTES; CELL COUNT; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; FEMALE; GLYCOSIDES; MESENCEPHALON; NERVE GROWTH FACTORS; NEURONS; ORGAN CULTURE TECHNIQUES; PREGNANCY; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; S100 PROTEINS; SPIROSTANS; TYROSINE 3-MONOOXYGENASE;

EID: 38049085832     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21465     Document Type: Article

References (60)

1. af Bjerkén S, Boger HA, Nelson M, Hoffer BJ, Granholm A-C, Strömberg I. 2007. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Res 1133:10-19.
2. Barker R, Dunnett S, Faissner A, Fawcett JW. 1996. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol 141:79-93.
3. Berglöf E, af Bjerkén S, Strömberg I. 2007. Glial influence on nerve fiber formation from rat ventral mesencephalic organotypic tissue culture. J Comp Neurol 501:431-442.
4. Bicknese A, Sheppard A, O'Leary D, Pearlman A. 1994. Thalamocortical axons extend along a chondroitin sulfate protcoglycan-ennched pathway coincident with the neocortical subplate and distinct from the efferent path. J Neurosci 14:3500-3510.
5. Björklund A, Stenevi U. 1979. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560.
6. Carey D, Rafferty C, Todd M. 1987. Effects of inhibition of proteoglycan synthesis on the differentiation of cultured rat Schwann cells. J Cell Biol 105:1013-1021.
7. Charvet I, Hemming F, Feuerstein C, Saxod R. 1998a. Mosaic distribution of chondroitin and keratan sulphate in the developing rat striatum: possible involvement of proteoglycans in the organization of the nigrostriatal system. Dev Brain Res 109:229-244.
8. Charvet I, Hemming F, Feuerstein C, Saxod R. 1998b. Transient compartmental expression of neurocan in the developing striatum of the rat. J Neurosci Res 51:612-618.
9. Chung S, Hedlund E, Hwang M, Kim DW, Shin B-S, Hwang D-Y, Kang UJ, Isacson O, Kim K-S. 2005. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol Cell Neurosci 28:241-252.
10. Clement A, Sugahara K, Faissner A. 1999. Chondroitin sulphate E promotes neurite outgrowth of rat embryonic day 18 hippocampal neurons. Neurosci Lett 3:125-128.
11. Cole G, McCabe C. 1991. Identification of a developmentally regulated keratan sulfate proteoglycan that inhibits cell adhesion and neurite outgrowth. Neuron 7:1007-1018.
12. Davies S, Goucher D, Silver J. 1999. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 19:5810-5822.
13. Dou C, Levine J. 1995. Differential effects of glycosaminoglycans on neurite growth on Laminin and L1 substrates. J Neurosci 15:8053-8066.
14. Faissner A, Clement A, Lochter A, Streit A, Mandl C, Schachner M. 1994. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J Cell Biol 126:783-799.
15. Fernaud-Espinosa I, Nieto-Sampedro M, Bovolenta P. 1994. Differential effects of glycosaminoglycans on neurite outgrowth from hippocampal and thalamic neurones. J Cell Sci 107:1437-1448.
16. Fichard A, Verna J, Olivares J, Saxod R. 1991. Involvement of a chondroitin sulfate proteoglycan in the avoidance of chick epidermis by dorsal root ganglia fibers: a study using b-D-xyloside. Dev Biol 148:1-9.
17. Gates M, Laywell E, Fillmore H, Steiner D. 1996. Astrocytes and extracellular matrix in adult mice following intracerebral transplantation of embryonic ventral mesencephalon or lateral ganglionic eminence. Neuroscience 74:579-597.
18. Gates MA, O'Brian TF, Faissner A, Steindler DA. 1993. Neuron-glial interactions during in vivo and in vitro development of the nigrostriatal circuit. J Chem Neuroanat 6:179-189.
19. Geisert E, Bidanset D. 1993. A central nervous system keratan sulfate preoteoglycan: localization to boundaries in the neonatal rat brain. Dev Brain Res 75:163-173.
20. Grimpe B, Silver J. 2004. A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J Neurosci 24:1393-1397.
21. Gähwiler BH, Capogna D, McKinney RA, Thompson SM. 1997. Organotypic slice cultures: a technique has come of age. Trends Neurosci 20:471-477.
22. Hudson J, Bickford P, Johansson M, Hoffer BJ, Strömberg I. 1994. Target and neurotransmitter specificity of fetal central nervous system transplants: Importance for functional reinnervation. J Neurosci 14:283-290.
23. Inatani M, Honjo M, Otori Y, Oohira A, Kido N, Tano Y, Honda Y, Tanihara H. 2001. Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture. Invest Ophtal Vis Sci 42:1930-1938.
24. Johansson S, Strömberg I. 2002. Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon. J Comp Neurol 443:237-249.
25. Johansson S, Strömberg I. 2003. Fetal lateral ganglionic eminence attracts one of two morphologically different types of tyrosine hydroxylase-positive nerve fibers formed by cultured vetral mesencephalon. Cell Transplant 12:243-255.
26. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJG, Mufson EJ, Sandberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP, Olanow CW. 1995. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124.
27. Kordower JH, Rosenstein JM, Collier TJ, Burke MA, Chen E-Y, Li JM, Martel L, Levey AE, Mufson EJ, Freeman TB, Olanow CW. 1996. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 370:203-230.
28. Lafont F, Rouget M, Triller A, Prochiantz A, Rousselet A. 1992. In vitro control of neuronal polarity by glycosaminoglycans. Development 114:17-29.
29. Lander C, Zhang H, Hockfield S. 1998. Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan. J Neurosci 18(1):174-183.
30. Lane M, Solursh M. 1988. Dependence of sea urchin primary mesenchyme cell migration on xyloside- and sulfate-sensitive cell surface-associated components. Dev Biol 127:78-87.
31. Lindvall O. 1997. Neural transplantation: a hope for patients with Parkinson's disease. Neurol Rep 8(14):iii-x.
32. Macé K, Saxod R, Feuerstein C, Sadoul R, Hemming FJ. 2002. Chondroitin and keratan sulfates have opposing effects on attachment and outgrowth of ventral mesencephalic explants in culture. J Neurosci Res 70:46-56.
33. McAdams B, Mcloon S. 1995. Expression of chondroitin sulfate and keratan sulfate proteoglycans in the path of growing retinal axons in the developing chick. J Comp Neurol 352:594-606.
34. McCaffery P, Drager UC. 1994. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci U S A 91:7772-7776.
35. McKeon RJ, Hoke A, Silver J. 1995. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 136:32-43.
36. Meyer-Puttlitz B, Milev P, Junker E, Zimmer I, Margolis RU, Margolis RK. 1995. Chondroitin sulfate and chondroitin/keratan sufate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan. J Neurochem 65:2327-2337.
37. Moon L, Asher R, Rhodes K, Fawcett J. 2001. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nature Neurosci 4:465-466.
38. Moon LDF, Asher RA, Rhodes KE, Fawcett JW. 2002. Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neurosci 109:101-117.
39. Niederöst B, Zimmerman D, Schwab M, Bandtlow C. 1999. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J Neurosci 20:8979-8989.
40. O'Brien TF, Faissner A, Schachner M, Steidler DA. 1992. Afferent-boundary interactions in the developing neostriatal mosaic. Dev Brain Res 65:259-267.
41. Olson L, Seiger Å, Fuxe K. 1972. Heterogeneity of striatal and limbic dopamine innervation: Highly fluorescent islands in developing and adult rats. Brain Res 44:283-288.
42. Perlow M, Freed W, BJ .H, Seiger Å, Olson L, Wyatt RJ. 1979. Brain grafts reduce motor abnormalities produced by destruction of the nigrostriatal dopamine system. Science 204:643-647.
43. Pindzola R, Doller C, Silver J. 1993. Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesion. Dev Biol 156(1):34-48.
44. Powell EM, Geller HM. 1999. Dissection of astrocyte-mediated cues in neuronal guidance in process extension. Glia 26:73-83.
45. Properzi F, Carulli D, Asher RA, Muir E, Camargo LM, van Kuppevelt TH, ten Dam GB, Furukawa Y, Mikami T, Sugahara K, Toida T, Geller HM, Fawcett JW. 2005. Chondoitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur J Neurosci 21:378-390.
46. Ratner N, Bunge R, Glaser L. 1985. A neuronal cell surface heparan sulfate proteoglycan is required for dorsal root ganglion neuron stimulation of Schwann cell proliferation. J Cell Biol 101:744-754.
47. Schwartz N. 1977. Regulation of chondroitin sulfate synthesis. J Biol Chem 252:6316-6321.
48. Shults CW, Kimber TA. 1992. Mesencephalic dopaminergic cells exhibit increased density of neural cell adhesion molecule and polysiolic acid during development. Dev Brain Res 65:161-172.
49. Smith-Thomas L, Stevens J, Fok-Seang J, Faissner A, Rogers J, Fawcett J. 1995. Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J Cell Sci 108:1307-1315.
50. Snow DM, Lemmon V, Carrino DA, Caplan AI, Silver J. 1990. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 109:111-130.
51. Steinmetz MP, Horn KP, Tom VJ, Miller JH, Busch SA, Nair D, Silver DJ, Silver J. 2005. Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone int he mammalian spinal cord. J Neurosci 25:8066-8076.
52. Strömberg I, Bickford P. 1996. Reduced ageing effects of striatal neuronal discharge rate by aged ventral mesencephalic grafts. Neuro Rep 7:693-696.
53. Strömberg I, Björklund L, Förander P. 1997. The age of striatum determines the pattern and extent of dopaminergic innervation: a nigrostriatal double graft study. Cell Transplant 6:287-296.
54. Strömberg I, Bygdeman M, Almqvist P. 1992. Target-specific outgrowth from human mesencephalic tissue grafted to cortex or ventricle of immunosuppressed rats. J Comp Neurol 315:445-456.
55. Strömberg I, Törnqvist N, Johansson S, Bygdeman M, Almqvist P. 2001. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons. Micros Res Tech 54:287-297.
56. Takeshima T, Johnston JM, Commissiong JW. 1994. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci 14:4769-4779.
57. Tropea D, Caleo M, Maffei L. 2003. Synergistic effects of brain-derived neurotrophic factor and chondroitinase ABC on retinal fiber sprouting after denervation of the superior colliculus in adult rats. J Neurosci 23:7034-7044.
58. Törnqvist N, Björklund L, Strömberg I. 2001. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting. Exp Neurol 169:329-339.
59. Zuo J, Neubauer D, Dyes K, Ferguson T, Muir D. 1998. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp Neurol 154:654-662.
60. Zuo J, Neubauer D, Graham J, Krekoski CA, Ferguson TA, Muir D. 2002. Regeneration of axons after nerve transection repair is enhanced by degradation of chondroitin sulfate proteoglycan. Exp Neurol 176: 221-228.